Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts

被引:99
作者
Hafner, N. [1 ]
Driesch, C. [1 ]
Gajda, M. [2 ]
Jansen, L. [1 ]
Kirchmayr, R. [3 ]
Runnebaum, I. B. [1 ]
Duerst, M. [1 ]
机构
[1] FSU Jena, Frauenklin, D-07743 Jena, Germany
[2] Klinikum Friedrich Schiller Univ, Inst Pathol, Jena, Germany
[3] Gynakol Praxis, Ulm, Germany
关键词
cervical cancer; HPV16; oncogene expression; physical state; integration;
D O I
10.1038/sj.onc.1210791
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Virus integration into the host genome is a characteristic step during cervical carcinogenesis. Experimental data provide evidence that integration could result in increased levels of oncogene (E6/E7) transcripts. This is the first study in which the level of viral transcripts is correlated to the physical state of the viral genome in cervical intraepithelial neoplasia (CIN) and cervical carcinomas (CxCa). Using the APOT-assayinteg rate-derived transcripts only were detected in 3/28 (11%) CIN and in 28/55 (51%) carcinomas, respectively. The remaining biopsies contained either episome-derived transcripts only or both mRNA species. SybrGreen real time reverse transcriptase-PCR assays were used to quantify viral gene expression for (i) all transcripts initiated from p97, (ii) full-length E6, (iii) E6*I and (iv) E5 transcripts (E6/E7) transcript levels showed a broad distribution but similar median values irrespective of histopathological grading and physical state of the viral genome. Biopsies with integrate-derived transcripts only generally lacked E5-specific mRNA. Our data do not support the hypothesis that HPV integration invariably results in high levels of oncogene transcripts. Instead, constitutive expression of oncogene transcripts rather than the level of expression appears to be decisive for transformation and the maintenance of the malignant phenotype.
引用
收藏
页码:1610 / 1617
页数:8
相关论文
共 46 条
  • [21] Klaes R, 1999, CANCER RES, V59, P6132
  • [22] Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.3.CO
  • [23] 2-C
  • [24] DNA aneuploidy and integration of human papillomavirus type 16 E6/E7 oncogenes in Intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri
    Melsheimer, P
    Vinokurova, S
    Wentzensen, N
    Bastert, G
    Doeberitz, MV
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (09) : 3059 - 3063
  • [25] Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers
    Middleton, K
    Peh, W
    Southern, S
    Griffin, H
    Sotlar, K
    Nakahara, T
    El-Sherif, A
    Morris, L
    Seth, R
    Hibma, M
    Jenkins, D
    Lambert, P
    Coleman, N
    Doorbar, J
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (19) : 10186 - 10201
  • [26] Comparison of human papillomavirus messenger RNA and DNA detection:: A cross-sectional study of 4,136 women &lt;30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion
    Molden, T
    Kraus, I
    Karlsen, F
    Skomedal, H
    Nygård, JF
    Hagmar, B
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (02) : 367 - 372
  • [27] Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
    Münger, K
    Basile, JR
    Duensing, S
    Eichten, A
    Gonzalez, SL
    Grace, M
    Zacny, VL
    [J]. ONCOGENE, 2001, 20 (54) : 7888 - 7898
  • [28] Mechanisms of human papillomavirus-induced oncogenesis
    Münger, K
    Baldwin, A
    Edwards, KM
    Hayakawa, H
    Nguyen, CL
    Owens, M
    Grace, M
    Huh, K
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (21) : 11451 - 11460
  • [29] Munoz N, 1992, IARC Sci Publ, P251
  • [30] Nakagawa S, 2000, J MED VIROL, V62, P251, DOI 10.1002/1096-9071(200010)62:2<251::AID-JMV18>3.0.CO